Form 4: NeuroOne Medical Technologies Executive Steve Mertens Reports Stock Disposal
SEC Form 4 Filing
Chief Technology Officer Steve Mertens disposed of 252 shares of NeuroOne Medical Technologies stock to cover tax obligations.
Summary
- On July 31, 2024, Steve Mertens, Chief Technology Officer of NeuroOne Medical Technologies Corp, disposed of 252 shares of common stock.
- The transaction was executed at a price of $0.75 per share.
- Following the transaction, Mertens directly owns 174,747 shares of NeuroOne Medical Technologies Corp.
- The transaction was reported on August 2, 2024.
Sentiment
Score: 5
Explanation: This is a neutral report of an insider transaction. The disposal of shares could be for various reasons, including covering tax obligations, and doesn't inherently indicate a positive or negative outlook for the company.
Industry Context
Form 4 filings are a routine part of the US financial market and are required by the SEC to ensure transparency of trading by corporate insiders.
Key Dates
| Date | Description |
|---|---|
| 07/31/2024 | Date of transaction: Steve Mertens disposed of shares. |
| 08/02/2024 | Date of report filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.